Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Drug Reactions01:27

Allergic Drug Reactions

806
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
806
Hypersensitivities01:30

Hypersensitivities

484
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
484
Allergic Reactions02:06

Allergic Reactions

27.2K
Overview
27.2K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
T Cell Types and Functions01:24

T Cell Types and Functions

897
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
897
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

728
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
728

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unsupervised Machine-Learning-Based Endotype Discovery Using Iterative Resampling in Dupilumab-Treated Patients.

International journal of molecular sciences·2026
Same author

EAACI Guidelines on Environmental Science for Allergy and Asthma-Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy.

Allergy·2026
Same author

Bridging Rare to Common Diseases: Precision Medicine and the Transforming Landscape of Pediatric Allergy and Immunology.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Beyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation.

Irish journal of medical science·2026
Same author

Hantavirus Outbreak in a Travel-Associated Cruise Ship.

Allergy·2026
Same author

Metabolomic Changes Following Oral Immunotherapy in Multi-Food Allergic Children.

Allergy·2026
Same journal

FAM234A acts as a switch between Th17 and Treg cell fate decisions that control inflammatory bowel disease.

Cellular & molecular immunology·2026
Same journal

Targeting SPP1 requires moving beyond ligand blockade.

Cellular & molecular immunology·2026
Same journal

USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation.

Cellular & molecular immunology·2026
Same journal

Itaconate induces noncanonical AIM2-dependent PANoptosis in sepsis.

Cellular & molecular immunology·2026
Same journal

EZH2: an epigenetic governor of T-cell Ca<sup>2+</sup> homeostasis.

Cellular & molecular immunology·2026
Same journal

Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells.

Cellular & molecular immunology·2026
See all related articles

Related Experiment Video

Updated: May 27, 2025

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
08:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

1.8K

Type 2 immunity in allergic diseases.

Ismail Ogulur1, Yasutaka Mitamura1, Duygu Yazici1

  • 1Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.

Cellular & Molecular Immunology
|February 17, 2025
PubMed
Summary
This summary is machine-generated.

Type 2 immunity, crucial for fighting parasites, drives allergic diseases like asthma. Understanding its cellular mechanisms offers new therapeutic targets for allergies, though personalized approaches are still needed.

Keywords:
Alarminsallergic diseasesbiologicsepithelial barriertype 2 immunity

More Related Videos

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
10:25

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

6.8K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.5K

Related Experiment Videos

Last Updated: May 27, 2025

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
08:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

1.8K
Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
10:25

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

6.8K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.5K

Area of Science:

  • Immunology
  • Allergology
  • Molecular Biology

Background:

  • Type 2 immunity protects against parasites and toxins, maintaining epithelial barriers.
  • It involves innate lymphoid cells (ILCs), T cells, B cells, and effector cells like eosinophils and mast cells.
  • Dysfunction in type 2 immunity underlies various allergic conditions.

Purpose of the Study:

  • To review advancements in understanding type 2 immunity's role in allergic diseases.
  • To highlight the cellular and molecular mechanisms involved.
  • To discuss current and future therapeutic strategies.

Main Methods:

  • Review of cellular and molecular mechanisms of type 2 immunity.
  • Analysis of the roles of cytokines (IL-4, IL-5, IL-13) and immune cells.
  • Evaluation of current biologic therapies targeting IL-4/IL-13, IL-5, and IgE.

Main Results:

  • Type 2 immunity involves a complex interplay of innate and adaptive immune cells, including ILC2s, Th2 cells, and IgE production.
  • Key cytokines IL-4, IL-5, and IL-13 are central to allergic inflammation and barrier dysfunction.
  • Biologics targeting these pathways show promise but do not benefit all patients.

Conclusions:

  • Significant progress in understanding type 2 immunity has been made.
  • Targeting specific pathways with biologics is effective for many, but not all, allergic diseases.
  • Further research is needed for personalized treatment approaches in severe allergic conditions.